Keeping Current

521 Epizód

1. Adherence to Lipid-Lowering Therapies: How Can We Tackle This Barrier Better?

   Közzétéve: 2023. 06. 06.
2. Adherence to Lipid-Lowering Therapies: How Can We Tackle This Barrier Better?

   Közzétéve: 2023. 06. 06.
3. A Patient Is Waiting for a Liver Transplant: What Can We Do Now and What Could We Have Done Better?

   Közzétéve: 2023. 05. 31.
4. Reducing the Risks of Hyperkalemia in the Treatment of Heart Failure and Chronic Kidney Disease: What It Means for Management Teams

   Közzétéve: 2023. 05. 31.
5. Dengue Prevention: Integrating Vaccination Into Comprehensive Control Strategies Across Populations

   Közzétéve: 2023. 05. 22.
6. Early-Stage Resectable Non-Small Cell Lung Cancer: Sharing Patient Perspectives

   Közzétéve: 2023. 05. 08.
7. Gaining Control With Early Combination Lipid-Lowering Therapy: Applying Learnings From the Queen's Gambit

   Közzétéve: 2023. 05. 03.
8. Looking Forward to Thriving With HIV: Interventions to Improve and Maintain Health in People With HIV

   Közzétéve: 2023. 05. 01.
9. Three Cardiovascular Risk Cases: Why and Who Should We Be Testing for Lp(a)

   Közzétéve: 2023. 04. 18.
10. Well Begun Is Half Done: Why and How Do We Assess Activity of the Complement Pathway in the Clinic?

    Közzétéve: 2023. 04. 14.
11. What’s New in Diabetic Eye Disease Technologies

    Közzétéve: 2023. 03. 31.
12. Biosimilars in Multiple Sclerosis: Entering a New Era of Biologic Therapy

    Közzétéve: 2023. 03. 30.
13. Are We Ready for Biosimilars in Multiple Sclerosis? Experts Discuss Lessons From Other Immune-Mediated Diseases

    Közzétéve: 2023. 03. 29.
14. Global Perspectives on Anti-Vascular Endothelial Growth Factor: If, When, and How to Switch

    Közzétéve: 2023. 03. 29.
15. Clinical Trials in Focus: Durability of Intravitreal Anti-Vascular Endothelial Growth Factor Therapies

    Közzétéve: 2023. 03. 28.
16. Safeguarding the CKD Patient With or Without Diabetes in Primary Care: Quick Questions, Rapid Replies

    Közzétéve: 2023. 03. 27.
17. Optimizing Treatments in Advanced Systemic Mastocytosis With Associated Hematological Neoplasm

    Közzétéve: 2023. 03. 27.
18. Diabetes Dialogue Part 2: Who Are Candidates for GLP-1 Receptor Agonist Therapy in Primary Care?

    Közzétéve: 2023. 03. 24.
19. Challenging the Harmful Myths About ASCVD Management: The Experts Set the Record Straight

    Közzétéve: 2023. 03. 23.
20. What Is the Expert Accord on Identifying and Protecting the Patient at Early Stage of CKD?

    Közzétéve: 2023. 03. 16.